• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Interferon gamma-1b Product Approval Information - Licensing Action 2/10/00

Proper name: Interferon gamma-1b
Tradename: Actimmune
Manufacturer: InterMune Pharmaceuticals, Inc, Palo Alto, CA, License #1267
New Indication for Use:Delaying time to disease progression in patients with severe, malignant osteopetrosis
Approval Date: 2/10/2000
Type of submission: Biologics license supplement


Approval Letter (PDF)